Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07508124 · ClinicalTrials.gov registry record · Phase 4
Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study
A Phase 4 study, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT07508124 is a Phase 4 study that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 40 participants.
The verdict
NCT07508124, a Phase 4 study, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.
Interventions
- DRUG Placebo cream
- DRUG betamethasone valerate 0.1% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07508124
The ClinicalTrials.gov registry entry for NCT07508124 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo cream is the first listed.
NCT07508124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07508124 about?
NCT07508124 is a clinical study titled "Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study". The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Ma...
What is the current status of trial NCT07508124?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2026-04. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07508124?
The interventions under investigation include: Placebo cream (DRUG), betamethasone valerate 0.1% cream (DRUG).
Who is sponsoring clinical trial NCT07508124?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.